BLOOD PRESSURE MONITOR, MODEL KP-7000

K032492 · K-Jump Health Co., Ltd. · DXN · Sep 9, 2003 · Cardiovascular

Device Facts

Record IDK032492
Device NameBLOOD PRESSURE MONITOR, MODEL KP-7000
ApplicantK-Jump Health Co., Ltd.
Product CodeDXN · Cardiovascular
Decision DateSep 9, 2003
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.1130
Device ClassClass 2

Intended Use

The device is intended to measure the systolic and diastolic blood pressure and pulse rate (heart rate) by using an inflating cuff. The device is indicated for use with adults.

Device Story

Electronic blood pressure monitor; wrist-worn; utilizes inflating cuff, bellows sensor, internal air pump, leakage valve, and exhaust valve. Device measures systolic/diastolic blood pressure and pulse rate; displays results on LCD screen. Operated by user; intended for adult population. Provides non-invasive monitoring; assists in tracking cardiovascular metrics. Minor design updates include bellows sensor integration and simultaneous display of blood pressure and heart rate on a single screen for user convenience.

Clinical Evidence

Clinical trial performed in accordance with AAMI/ANSI SP10 to verify in-vivo measurement accuracy. Results demonstrate accurate measurement of blood pressure and pulse rate.

Technological Characteristics

Electronic blood pressure monitor; components include inflating cuff, LCD display, bellows sensor, air pump, leakage/exhaust valves, battery. Complies with AAMI/ANSI SP10 (1992/A1:1996), IEC 60601-1-1 (2000), IEC 60601-1-2 (2002), EN61000-4-2 (1995), and EN61000-4-3 (2002).

Indications for Use

Indicated for use in adults to measure systolic and diastolic blood pressure and pulse rate via an inflating wrist cuff.

Regulatory Classification

Identification

A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # SEP = 9 2003 # 510(k) Summary ## Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared Mr. C.M. Daniel Tseng K-iump Health Co., Ltd. No. 56 Wu Kung 5th Road Wu Ku Industrial Park Taipei Hsien Taiwan Phone: + 886 2 22991378 Facsimile: + 886 2 22991386 Date Prepared: August 11, 2003 #### Name of Device Wristwatch Blood Pressure Monitor Model KP-7000 #### Name/Address of Sponsor K-jump Health Co., Ltd. No. 56 Wu Kung 5th Road Wu Ku Industrial Park Taipei Hsien Taiwan Phone: + 886 2 22991378 Facsimile: + 886 2 22991386 Contact Person: T.T. Lin #### Common or Usual Name Wrist Blood Pressure Monitor #### Classification Name Class II § 870.1130; System, Measurement, Blood Pressure, Non-Invasive #### Predicate Device - K-jump Health Co., Ltd.'s Wristwatch BPM Blood Pressure Monitor Model I. KP-6120. - II. MicroLife's Wrist Watch Blood Pressure Monitor Model BP-3BU1-3. {1}------------------------------------------------ ### Intended Use/Indications for Use The device is intended to measure the systolic and diastolic blood pressure and pulse rate (heart rate) by using an inflating cuff. The device is indicated for use with adults. ## Technological Characteristics The device is an electronic blood pressure monitor. The device consists of an inflating cuff, a LCD display, a bellows sensor, an internal air pump, a leakage valve, an exhaust valve, a battery power resource, and keys for operation. ## Performance Data The Wristwatch Blood Pressure Monitor Model KP-7000 complies with the following FDA-recognized consensus standards, to the extent that these standards are applicable to this device: - AAMI/ANSI SP10 (1992 / A1:1996); ● - IEC 60601-1-1 (2000); and . - IEC 60601-1-2 (2002). ● The KP-7000 also complies with the following additional standards: - EN61000-4-2 (1995); and ● - . EN61000-4-3 (2002). In accordance with AAMI/ANSI SP10, a clinical trial also was performed to verify the accuracy of in-vivo measurement. The results demonstrate that the KP-7000 accurately measures the patient's blood pressure and pulse rate. ### Substantial Equivalence The KP-7000 has the same intended use and indications for use as K-Jump's Wristwatch Blood Pressure Monitor Model KP-6120 and MicroLife's Model BP-3BU1. The KP-7000 has the same technological characteristics as the the KP6120 except: (1) that the KP-7000 uses a bellows sensor; (2) the KP-7000 has a lower maximum storage temperature; and (3) the KP-7000 displays blood pressure {2}------------------------------------------------ and heart rate on the same screen simultaneously rather than on subsequent, alternating screens. Microlife's Model BP-3BU1 also uses a bellows sensor and has the same maximum storage temperature as the KP-7000. Thus, the minor differences between the KP-7000 and the predicate devices are not new technological characteristics for wrist watch blood pressure monitors. The modification of the device's LCD display was made for user convenience. Therefore, these minor technological differences do not raise any new questions of safety or effectiveness. Accordingly, the KP-7000 is substantially equivalent to its predicate devices. {3}------------------------------------------------ Public Health Service Image /page/3/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo is circular in shape, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter of the circle. In the center of the circle is a stylized image of an eagle with its wings spread. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 SEP - 9 2003 K-Jump Health Co., Ltd c/o Mr. Jonathan S. Kahan Hogan & Hartson L.L.P. 555 Thirteen Street, N.W. Washington, D.C. 20004-1109 Re: K032492 Trade Name: Wristwatch Blood Pressure Monitor Model KP-7000 Regulation Number: 21 CFR 870.1130 Regulation Name: Non-invasive blood pressure monitor Regulatory Class: Class II (two) Product Code: DXN Dated: August 12, 2003 Received: August 12, 2003 Dear Mr. Kahan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must {4}------------------------------------------------ Page 2 - Mr. Jonathan S. Kahan comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, K. Dalton Tull Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ # Indications for Use Statement 510(k) Number (if Known): K432492 ______________________________________________________________________________________________________________________________________________________________________ Device Name: KP-7000 Wristwatch Blood Pressure Monitor Model Indication for Use: The KP-7000 is intended to measure the systolic and diastolic blood pressure and pulse rate (heart rate) by using an inflating cuff which is wrapped around the wrist. It is indicated for use in adults. #### (PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 C.F.R. 801.109) OR Over-The-Counter Use X (Optional Format 1-2-96) N. Deaton 510(k) Number K032492
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%